Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;18(1):140-155.
doi: 10.1007/s13311-021-01019-4. Epub 2021 Apr 20.

Restless Legs Syndrome: Contemporary Diagnosis and Treatment

Affiliations
Review

Restless Legs Syndrome: Contemporary Diagnosis and Treatment

Thomas R Gossard et al. Neurotherapeutics. 2021 Jan.

Abstract

Restless legs syndrome (RLS) is characterized by an uncomfortable urge to move the legs while at rest, relief upon movement or getting up to walk, and worsened symptom severity at night. RLS may be primary (idiopathic) or secondary to pregnancy or a variety of systemic disorders, especially iron deficiency, and chronic renal insufficiency. Genetic predisposition with a family history is common. The pathogenesis of RLS remains unclear but is likely to involve central nervous system dopaminergic dysfunction, as well as other, undefined contributing mechanisms. Evaluation begins with a thorough history and examination, and iron measures, including ferritin and transferrin saturation, should be checked at presentation and with worsened symptoms, especially when augmentation develops. Augmentation is characterized by more intense symptom severity, earlier symptom occurrence, and often, symptom spread from the legs to the arms or other body regions. Some people with RLS have adequate symptom control with non-pharmacological measures such as massage or temperate baths. First-line management options include iron-replacement therapy in those with evidence for reduced body-iron stores or, alternatively, with prescribed gabapentin or pregabalin, and dopamine agonists such as pramipexole, ropinirole, and rotigotine. Second-line therapies include intravenous iron infusion in those who are intolerant of oral iron and/or those having augmentation with intense, severe RLS symptoms, and opioids including tramadol, oxycodone, and methadone. RLS significantly impacts patients' quality of life and remains a therapeutic area sorely in need of innovation and a further pipeline of new, biologically informed therapies.

Keywords: Alpha-2-delta ligand; Cardiovascular risk; Dopamine agonist; Iron deficiency.; Opiate; Periodic leg movements; Periodic limb movement disorder; Restless legs syndrome; Treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Periodic leg movements (PLMS) of sleep during polysomnography PLMs are shown in channel 7 (linked anterior tibialis). Shown is a 2-min epoch during N2 sleep. This patient with a history of longstanding restless legs syndrome (RLS) had a periodic limb movement index (PLMI) that was highly elevated at 127/h

References

    1. Willis T, Crooke W, Bassett T, Real Colegio de Cirugía de San C. The London practice of physick, or The whole practical part of physick. London: printed for Thomas Basset... and William Crooke... 1685; 10(6)672.
    1. Ekbom KA. Restless legs syndrome. Neurology. 1960;10(9):868-. - PubMed
    1. Walters AS, Aldrich MS, Allen R, Ancoli-Israel S, Buchholz D, Chokroverty S, et al. Toward a better definition of the restless legs syndrome. Movement Disorders. 1995;10(5):634–642. - PubMed
    1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–119. - PubMed
    1. Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15(8):860–873. - PubMed

Publication types

MeSH terms

Substances